Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesCell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077Full text available |
|
2 |
Material Type: Article
|
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceProceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (38) [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Sep 21, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2106845118 ;PMID: 34493582Full text available |
|
3 |
Material Type: Article
|
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based DesignFrontiers in immunology, 2021-06, Vol.12 [Peer Reviewed Journal]Copyright © 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2021.710263 ;PMID: 34267764Full text available |
|
4 |
Material Type: Article
|
Rapid and automated design of two-component protein nanomaterials using ProteinMPNNProceedings of the National Academy of Sciences - PNAS, 2024-03, Vol.121 (13), p.e2314646121-e2314646121 [Peer Reviewed Journal]Copyright National Academy of Sciences Mar 26, 2024 ;Copyright © 2024 the Author(s). Published by PNAS. 2024 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2314646121 ;PMID: 38502697Full text available |
|
5 |
Material Type: Article
|
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceCell Reports, 2022-08, Vol.40 (9), p.111299-111299, Article 111299 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.111299 ;PMID: 35988541Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityNature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199Full text available |
|
7 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in micenpj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518Full text available |
|
8 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesbioRxiv, 2021-032021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesbioRxiv, 2021-022021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and micebioRxiv, 2022-022022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2022.02.07.479468Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based designbioRxiv, 2021-052021. This article is published under https://creativecommons.org/publicdomain/zero/1.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.05.15.444222Digital Resources/Online E-Resources |